FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15914911000001101: Nicotinic acid 1g / Laropiprant 20mg modified-release tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56374301000001112 Nicotinic acid 1g / Laropiprant 20mg modified-release tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56374401000001116 Nicotinic acid 1g / Laropiprant 20mg modified-release tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tabletmodified-release.oral ontology form and route true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Is a Laropiprant + Nicotinic acid true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Has specific active ingredient Nicotinic acid true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Has specific active ingredient Laropiprant true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Has active ingredient Nicotinic acid true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tredaptive 1000mg/20mg modified-release tablets (Organon Pharma (UK) Ltd) Is a True Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets 56 tablet Has VMP True Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Inferred relationship Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets 28 tablet Has VMP True Nicotinic acid 1g / Laropiprant 20mg modified-release tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start